Watson Pharmaceuticals, Inc. Promotes Patricia Eisenhaur to VP Investor Relations and Corporate Communications

CORONA, CA--(Marketwire - May 18, 2009) -

"Since joining the company, Patty has played a key role in building our investor relations function and raising Watson's visibility with shareholders, analysts and the media," said Paul Bisaro, Watson's President and Chief Executive Officer. "She brings unique qualities and a wealth of experience in a wide variety of communications which will serve us well as we position ourselves for further growth."

Ms. Eisenhaur joined Watson in 2001 as Director, Investor Relations and most recently was Executive Director Investor Relations. Prior to her tenure at Watson, Ms. Eisenhaur spent five years at ALZA Corporation (a Johnson & Johnson Company), in various investor relations positions of increasing responsibility. Ms. Eisenhaur will be transitioning to the company's Morristown, NJ location.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.